Ein Beitrag zu Rhenium(II)‐, Osmium(II)‐ und Technetium(II)‐Thionitrosylkomplexen vom Typ [M(NS)Cl4py]—: Darstellung,Strukturen und EPR‐Spektren

A Contribution to Rhenium(II)‐, Osmium(II)‐, and Technetium(II)‐Thionitrosyl‐Complexes: Preparation, Structures, and EPR‐Spectra The reaction of [Re^VINCl₄]^— and [Os^VINCl₄]^— with S₂Cl₂ leads to the formation of the thionitrosyl complexes [M^II(NS)Cl₄]^— (M = Re, Os) which could not be isolated as pure compounds. Addition of pyridine to the reaction mixture results in the formation of the stable compounds trans‐(Ph₄P)[Os^II(NS)Cl₄py], trans‐(Hpy)[Os^II(NS)Cl₄py], trans‐(Ph₄P)[Re^II(NS)Cl₄py], and cis‐(Ph₄P)[Re^II(NS)Cl₄py]. The crystal structure analyses show for trans‐(Ph₄P)[Os^II(NS)Cl₄py] (monoclinic, P2₁/n, a = 12.430(3)Å, b = 18.320(4)Å, c = 15.000(3)Å, β = 114.20(3)°, Z = 4), trans‐(Hpy)[Os^II(NS)Cl₄py] (monoclinic, P2₁/n, a = 7.689(1)Å, b = 10.202(2)Å, c = 20.485(5)Å, β = 92.878(4)°, Z = 4), trans‐(Ph₄P)[Re^II(NS)Cl₄py] (triclinic, P1¯, a = 9.331(5)Å, b = 12.068(5)Å, c = 15.411(5)Å, α = 105.25(1)°, β = 90.23(1)°, γ = 91.62(1)°, Z = 2), and cis‐(Ph₄P)[Re^II(NS)Cl₄py] (monoclinic, P2₁/c, a = 10.361(1)Å, b = 16.091(2)Å, c = 17.835(2)Å, β = 90.524(2)°, Z = 4) M‐N‐S angles in the range 168‐175°. This indicates a nearly linear coordination of the NS ligand. The metal atom is octahedrally coordinated in all cases. The rhenium(II) thionitrosyl complexes (5d⁵ “low‐spin” configuration, S = 1/2) are studied by EPR in the temperature range 295 > T > 130 K. In addition to the detection of the complexes formed during the reaction of [Re^VINCl₄]^— with S₂Cl₂ EPR investigations on diamagnetically diluted powders and single crystals of the system (Ph₄P)[Re^II/Os^II(NS)Cl₄py] are reported. The ^{185, 187}Re hyperfine parameters are used to get information about the spin‐density distribution of the unpaired electron in the complexes under study. [Tc^VINCl₄]^— reacts with S₂Cl₂ under formation of [Tc^II(NS)Cl₄]^— which is not stable and decomposes under S₈ elimination and rebuilding of [Tc^VINCl₄]^— as found by EPR monitoring of the reaction.     

A DFT study on the hydrolysis mechanism of NH‐tautomeric antitumors of [HL][trans‐RuCl4L(dmso‐S)]

The hydrolysis process of Ru (III) complex [Htrz][trans‐RuCl₄(1‐H‐1,2,4‐triazole)(dmso‐S)] 1 , a potential antitumor complex similar to the well‐known anticancer agent [ImH][trans‐RuCl₄(Im)(dmso‐S)] (NAMI‐A), has been investigated by using density functional theory (DFT) method, and the solvent effect was also considered and calculated by conductor‐like polarizable calculation model (CPCM). Meanwhile, the hydrolysis process of the NH‐tautomeric isomer, [Htrz][trans‐RuCl₄(4‐H‐1,2,4‐triazole)(dmso‐S)] 2 , was also modeled and predicted by the same methods. The structural characteristics and the detailed energy profiles for the hydrolysis processes of two isomers have been obtained. The analysis of thermodynamic and kinetic characteristics of hydrolysis reaction suggests the following: for the first hydrolysis step, the Complex 1 has lower hydrolysis rate than the reported anticancer drug NAMI‐A, and the result is in accordance with experimental one. However, Complex 1 has obviously higher hydrolysis rate than its isomer Complex 2 , and the result was reasonably explained in theory. For the second hydrolysis step, the formation of cis‐diaqua species is thermodynamic preferred to that of trans isomers. In addition, the trend in nucleophilic attack abilities (A) of hydrolysis products by pertinent biomolecules was revealed and predicted. © 2009 Wiley Periodicals, Inc. Int J Quantum Chem, 2010     

Binuclear dichlorido(η6‐p‐cymene)ruthenium(II) complexes with bis(nicotinate)‐ and bis(isonicotinate)‐polyethylene glycol ester ligands

Neutral binuclear ruthenium complexes 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 of the general formula [{RuCl₂(η⁶‐p‐cym)}₂ μ‐(N^∩N)] (N^∩N = bis(nicotinate)‐ and bis(isonicotinate)‐polyethylene glycol esters: (3‐py)COO(CH₂CH₂O)_nCO(3‐py) and (4‐py)COO(CH₂CH₂O)_nCO(4‐py), n =1–4), as well as mononuclear [RuCl₂(η⁶‐p‐cym)((3‐py)COO(CH₂CH₂OCH₃)‐κN)], complex 9 , were synthesized and characterized using elemental analysis and electrospray ionization high‐resolution mass spectrometry, infrared, ¹H NMR and ¹³C NMR spectroscopies. Stability of the binuclear complexes in the presence of dimethylsulfoxide was studied. Furthermore, formation of a cationic complex containing bridging pyridine‐based bidentate ligand was monitored using ¹H NMR spectroscopy. Ligand precursors, polyethylene glycol esters of nicotinic ( L1 · 2HCl– L4 · 2HCl and L9 · HCl) and isonicotinic acid dihydrochlorides ( L5 · 2HCl– L8 · 2HCl), binuclear ruthenium(II) complexes 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 and mononuclear complex 9 were tested for in vitro cytotoxicity against 518A2 (melanoma), 8505C (anaplastic thyroid cancer), A253 (head and neck tumour), MCF‐7 (breast tumour) and SW480 (colon carcinoma) cell lines. Copyright © 2014 John Wiley & Sons, Ltd.     

Synthesis of 2‐aminomethylpiperidine ruthenium(II) phosphine complexes and their applications in transfer hydrogenation of aryl ketones

The complex trans,cis‐[RuCl₂(PPh₃)₂(ampi)] (2) was prepared by reaction of RuCl₂(PPh₃)₃ with 2‐aminomethylpiperidine(ampi) (1). [RuCl₂(PPh₂(CH₂)_nPPh₂)(ampi) (n = 3, 4, 5)] (3–5) were synthesized by displacement of two PPh₃ with chelating phosphine ligands. All complexes (2–5) were characterized by ¹ H, ¹³C, ³¹P NMR, IR and UV‐visible spectroscopy and elemental analysis. They were found to be efficient catalysts for transfer hydrogen reactions. Copyright © 2012 John Wiley & Sons, Ltd.     

3,6‐Di­chloro‐4‐[2‐(4‐thia­morpholino)­ethanesulfanyl]­pyridazine and 3,6‐bis­(pyrazol‐1‐yl)‐4‐[2‐(4‐thia­mor­pho­lino)­ethanesulfanyl]­pyridazine

The trans–trans conformations adopted by the derivatized bis­(bidentate) chelating N₄‐donor ligand 3,6‐bis­(pyrazol‐1‐yl)‐4‐[2‐(4‐thia­morpholino)­ethanesulfanyl]­pyridazine, C₁₆H₁₉N₇S₂, and an intermediate in its formation, 3,6‐di­chloro‐4‐[2‐(4‐thia­morpholino)­ethanesulfanyl]­pyridazine, C₁₀H₁₃Cl₂N₃S₂, con­trast with the cis–cis conformation found previously for 3,6‐bis­(thio­phen‐2‐yl)­pyridazine [Ackers, Blake, Hill & Hubberstey (2002). Acta Cryst. C 58 , o640–o641], which places all four heteroatoms on the same side of the mol­ecule.     

In situ‐generated Ru(III)‐mediated ATRP from the polymeric Ru(III) complex in the absence of activator generation agents

Past research has examined the atom transfer radical polymerization (ATRP) with high oxidation state metal complexes and without the need for any additives such as reducing agent or free radical initiator. To extend this research, half‐metallocene ruthenium(III) (Ru(III)) catalysts were used for the polymerization of methyl methacrylate (MMA) for the first time. These catalysts were generated in situ simply by mixing phosphorus‐containing ligand and pentamethylcyclopentadienyl (Cp*) Ru(III) polymer ((Cp*RuCl₂)_n). The complexes in their higher oxidation state such as Cp*RuCl₂(PPh₃) were air‐stable, highly active, and removable catalysts for the ATRPs of MMA with both precision control of molecular weight and narrow polydispersity index. The addition of ppm amount of metal catalyst contributed to the formation of very well‐defined homopolymers and copolymers. © 2011 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem, 2011     

Synthesis,Characterization, Catalytic and Antibacterial Activity of Two Series of Dinuclear Ruthenium Sulphoxide Complexes Using 5,5¢‐Methylenebis(pyridine) as Bis‐chelating Bridging Ligand

The reaction of a new heterocyclic bidentate N containing spacer, (ligand) 5,5′‐methylenebis(pyridine) with ruthenium sulphoxide precursors resulted, dinuclear complexes. We herein report three formulations; [{cis,fac‐RuCl₂(so)₃}₂(μ‐mbp)].3so; [{trans,mer‐RuCl₂(so)₃₂}₂(μ‐mbp)].3so and [{trans‐RuCl₄(so)}₂(μ‐mbp)]^2?[X]₂⁺; where so = dimethyl‐sulfoxide/tetramethylenesulfoxide; mbp = 5,5′‐methylenebis(pyridine) and [X]⁺ = [(dmso)₂H]⁺, Na⁺ or [(tmso)H]⁺. These complexes were characterized on the basis of elemental analyses, molar conductance measurement, magnetic susceptibility, FT‐IR, ¹H‐NMR, ¹³C{¹H}‐NMR, electronic spectroscopy and FAB‐Mass spectrometry. Catalytic activity of these complexes has been investigated in hydrolysis of benzonitrile. All the complexes exhibit good antibacterial activity against gram‐negative bacteria Escherichia coli in comparison to Chloramphenicol.     

High‐Performance RuCl3 Catalyst Systems for Hydro‐Esterification of Methyl Formate and Ethylene

RuCl₃ catalyst system has many advantages for the hydro‐esterification of methyl formate and ethylene to methyl propionate. However, the unsatisfied performance restricts the development of this route. In this work, high‐performance RuCl₃ catalyst systems (RuCl₃‐[PPN]Cl‐Et₄NI and RuCl₃‐NaI) are firstly reported for this reaction. In RuCl₃‐[PPN]Cl‐Et₄NI catalyst system, the conversion of methyl formate and the selectivity to methyl propionate are 93.9% and 90.9% at mild reaction conditions (165°C, 2.5 MPa), respectively. Noticeably, a simple inorganic RuCl₃‐NaI catalyst system achieves 88.8% conversion of methyl formate and 97.6% selectivity to methyl propionate (86.7% yield) at same conditions. NaI, as a promoter, may inhibit the decomposition of methyl formate and be conducive to the formation of methyl propionate. The effects of solvents and promoters are investigated in detail. In addition, the reaction mechanism has been also analyzed. It is hoped to lay a certain foundation for further industrial application.     

Cyano­cobalt(III) complexes of penta‐ and tetra­dentate‐coordinated macrocyclic hexa­amines

The pendent‐arm macrocyclic hexa­amine trans‐6,13‐dimethyl‐1,4,8,11‐tetra­aza­cyclo­tetra­decane‐6,13‐diamine (L) may coordinate in tetra‐, penta‐ or hexa­dentate modes, depending on the metal ion and the synthetic procedure. We report here the crystal structures of two pseudo‐octa­hedral cobalt(III) complexes of L, namely sodium trans‐cyano­(trans‐6,13‐dimethyl‐1,4,8,11‐tetra­aza­cyclo­tetra­decane‐6,13‐diamine)cobalt(III) triperchlorate, Na[Co(CN)(C₁₃H₃₀N₆)](ClO₄)₃ or Na{trans‐[CoL(CN)]}(ClO₄)₃, (I), where L is coordinated as a penta­dentate ligand, and trans‐dicyano­(trans‐6,13‐dimethyl‐1,4,8,11‐tetra­aza­cyclo­tetra­decane‐6,13‐diamine)cobalt(III) trans‐dicyano­(trans‐6,13‐dimethyl‐1,4,8,11‐tetra­aza­cyclo­tetra­decane‐6,13‐diaminium)cobalt(III) tetra­perchlorate tetra­hydrate, [Co(CN)₂(C₁₄H₃₂N₆)][Co(CN)₂(C₁₄H₃₀N₆)](ClO₄)₄·4H₂O or trans‐[CoL(CN)₂]trans‐[Co(H₂L)(CN)₂](ClO₄)₄·4H₂O, (II), where the ligand binds in a tetra­dentate mode, with the remaining coordination sites being filled by C‐­bound cyano ligands. In (I), the secondary amine Co—N bond lengths lie within the range 1.944 (3)–1.969 (3) Å, while the trans influence of the cyano ligand lengthens the Co—N bond length of the coordinated primary amine [Co—N = 1.986 (3) Å]. The Co—CN bond length is 1.899 (3) Å. The complex cations in (II) are each located on centres of symmetry. The Co—N bond lengths in both cations are somewhat longer than in (I) and span a narrow range [1.972 (3)–1.982 (3) Å]. The two independent Co—CN bond lengths are similar [1.918 (4) and 1.926 (4) Å] but significantly longer than in the structure of (I), again a consequence of the trans influence of each cyano ligand.     

A New Route to Vitamin E Key‐Intermediates by Olefin Cross‐Metathesis

Ru‐Catalyzed olefin cross‐metathesis (CM) has been successfully applied to the synthesis of several phytyl derivatives ( 2b, 2d – f, 3b ) with a trisubstituted C?C bond, as useful intermediates for an alternative route to α‐tocopheryl acetate (vitamin E acetate; 1b ) (Scheme 1). Using the second‐generation Grubbs catalyst RuCl₂(C₂₁H₂₆N₂)(CHPh)PCy₃ (Cy = cyclohexyl; 4a ) and Hoveyda–Grubbs catalyst RuCl₂(C₂₁H₂₆N₂){CH‐C₆H₄(O‐ⁱPr)‐2} ( 4b ), the reactions were performed with various C‐allyl ( 5a – f, 7a,b ) and O‐allyl ( 8a – d ) derivatives of trimethylhydroquinone‐1‐acetate as substrates. 2,6,10,14‐Tetramethylpentadec‐1‐ene ( 6a ) and derivatives 6c – e of phytol ( 6b ) as well as phytal ( 6f ) were employed as olefin partners for the CM reactions (Schemes 2 and 5). The vitamin E precursors could be prepared in up to 83% isolated yield as (E/Z)‐mixtures.     

Synthesis and Cytotoxicity of Arene‐Ru Compounds Containing 4‐Nitroaniline or 2‐Halogenated 4‐Nitroaniline

The compounds [(η⁶‐p‐cymene)RuCl₂(4‐nitroaniline)] and [(η⁶‐p‐cymene)RuCl₂(2‐halogen‐4‐nitroaniline)] were synthesized and characterized by various means. The [(η⁶‐p‐cymene)RuCl₂(4‐nitroaniline)] and [(η⁶‐p‐cymene)RuCl₂(2‐fluoro‐4‐nitroaniline)] compounds were determined by X‐ray diffraction, appearing in a distorted piano‐stool type of arrangement with similar bond lengths and angles around the ruthenium. The compounds exhibited moderate to strong in vitro cytotoxicity against A549 and MCF‐7 human cancer cells. Substitution of heavy halogen atom on the ortho position of para‐nitroaniline weakened the cytotoxicity against both of MCF‐7 and A549, except the cases of fluorine substitution for hydrogen atom regarding A549 and bromine substitution for chlorine atom regarding MCF‐7, which showed minor deviation.     

Desulfuration and Cyclization of (Z)‐2‐[Amino(pyridine‐2‐yl)methylene]‐ hydrazonecarbothioamide in the Presence of Manganese(II)

The reaction of (Z)‐2‐[amino(pyridine‐2‐yl)methylene]hydrazonecarbothioamide (HAm4DH) with Mn(ClO₄)₂·6H₂O afforded different mononuclear or polynuclear manganese(II) complexes, the nature of which apparently depended on the solvent used. For example, in ethanol a compound of formula [Mn(HAm4DH)₂](ClO₄)₂ ( 1 ) was obtained, where HAm4DH coordinates as a common tridentate NNS donor, but the [Mn(bpy)₂(NCS)₂] complex ( 2 ) (bpy = 2,2'‐bipyridine) has also been obtained – probably due to C–N bond cleavage of the thiosemicarbazone. Nevertheless, in a basic aqueous medium [Mn(bpy)₃](ClO₄)₂·0.5bpy ( 3 ) is formed and there is structural evidence for chemical transformations of the thiosemicarbazone promoted by Mn^II. Thus, the sulfate in {[Mn(py)₄Mn(py)₂(H₂O)₂(μ‐SO₄)₂]·4H₂O}_n ( 4 ) or sulfate and cyclooctasulfur in [Mn(pta)₂(pdo)]₄(SO₄)₂·4H₂O·S₈] ( 5 ), where pta is 3‐(pyridin‐2‐yl)‐1,2,4‐triazol‐5‐amine and pdo is (2R,4R/2S,4S)‐pentane‐2,4‐diolato, arise from the desulfuration and oxidation of the thiosemicarbazone ligand. The structures of complexes 2 to 5 were established by single‐crystal X‐ray diffraction. The formation of pta is the result of the oxidative cyclization of HAm4DH. In the polynuclear complex 4 , the sulfate acts as an (O,O') bridge between alternating Mn(py)₂(H₂O)₂ and Mn(py)₄ centers. In the tetranuclear complex 5 , pta acts as a bischelating ligand through the N‐pyridine and N‐triazole, and pdo act as a bridge between two manganese atoms. It is also noteworthy that in complexes 4 and 5 hydrogen bonds give rise to different self‐assembly behaviour that leads to complicated supramolecular structures.     

Asymmetric Reduction of 2‐Chloro‐3‐oxo Esters by Transfer Hydrogenation

Asymmetric reduction of 2‐chloro‐3‐oxo esters was achieved by catalytic transfer hydrogenation using [RuCl₂(p‐cymene)](S,S)‐TsDPEN as the chiral catalyst and HCOOH‐Et₃N as the hydrogen source. Moderate to good yields (up to 85%) and good enantioselectivities (up to 98% ee) were obtained.     

Synthesis and structures of ruthenium di‐ and tricarbonyl complexes derived from 4,5‐diazafluoren‐9‐one

Carbon monoxide (CO) has recently been shown to impart beneficial effects in mammalian physiology and considerable research attention is now being directed toward metal–carbonyl complexes as a means of delivering CO to biological targets. Two ruthenium carbonyl complexes, namely trans‐dicarbonyldichlorido(4,5‐diazafluoren‐9‐one‐κ²N,N′)ruthenium(II), [RuCl₂(C₁₁H₆N₂O)(CO)₂], (1), and fac‐tricarbonyldichlorido(4,5‐diazafluoren‐9‐one‐κN)ruthenium(II), [RuCl₂(C₁₁H₆N₂O)(CO)₃], (2), have been isolated and structurally characterized. In the case of complex (1), the trans‐directing effect of the CO ligands allows bidentate coordination of the 4,5‐diazafluoren‐9‐one (dafo) ligand despite a larger bite distance between the N‐donor atoms. In complex (2), the cis disposition of two chloride ligands restricts the ability of the dafo molecule to bind ruthenium in a bidentate fashion. Both complexes exhibit well defined ¹H NMR spectra confirming the diamagnetic ground state of Ru^II and display a strong absorption band around 300 nm in the UV.     

Crystallographic report: [N,N′‐Bis‐(6‐methylpyrid‐2‐ylium)‐(1R,2R)‐1,2‐diaminocyclohexane] bis‐[(p‐cymene)‐ trichlororuthenate(II)]

The chiral compound (H₂cydiampy)[RuCl₃(p‐cymene)]₂ has been obtained in high yield by treating [RuCl₂(p‐cymene)]₂ with an excess of hydrochloric acid in the presence of one equivalent of N,N′‐bis‐(6‐methylpyrid‐2‐yl)‐(1R,2R)‐1,2‐diaminocyclohexane (cydiampy). It crystallizes in the chiral tetragonal space group P4₃2₁2, with half of the atoms of the dication related to the other half by a crystallographic C₂ axis that also makes equivalent the two anionic metal moieties. Copyright © 2005 John Wiley & Sons, Ltd.     

Synthesis and catalytic properties of 1‐alkyl‐2‐imidazolineruthenium(II) complexes

New [RuCl₂(imidazoline)(arene)] complexes have been prepared. The complexes were characterized by conventional spectroscopic methods and elemental analyses. Upon reaction with 1,1‐diphenylprop‐2‐ynol they generate catalyst precursors that can perform the cycloisomerization of diallyltosylamide into N‐tosyl‐α‐methylenepyrrolidine. Copyright © 2004 John Wiley & Sons, Ltd.     

[(NHC)(NHCewg)RuCl2(CHPh)] Complexes with Modified NHCewg Ligands for Efficient Ring‐Closing Metathesis Leading to Tetrasubstituted Olefins

Imidazolium salts (NHC_ewg ? HCl) with electronically variable substituents in the 4,5‐position (H,H or Cl,Cl or H,NO₂ or CN,CN) and sterically variable substituents in the 1,3‐position (Me,Me or Et,Et or iPr,iPr or Me,iPr) were synthesized and converted into the respective [AgI(NHC)_ewg] complexes. The reactions of [(NHC)RuCl₂(CHPh)(py)₂] with the [AgI(NHC_ewg)] complexes provide the respective [(NHC)(NHC_ewg)RuCl₂(CHPh)] complexes in excellent yields. The catalytic activity of such complexes in ring‐closing metathesis (RCM) reactions leading to tetrasubstituted olefins was studied. To obtain quantitative substrate conversion, catalyst loadings of 0.2–0.5 mol % at 80 °C in toluene are sufficient. The complex with the best catalytic activity in such RCM reactions and the fastest initiation rate has an NHC_ewg group with 1,3‐Me,iPr and 4,5‐Cl,Cl substituents and can be synthesized in 95 % isolated yield from the ruthenium precursor. To learn which one of the two NHC ligands acts as the leaving group in olefin metathesis reactions two complexes, [(FL‐NHC)(NHC_ewg)RuCl₂(CHPh)] and [(FL‐NHC_ewg)(NHC)RuCl₂(CHPh)], with a dansyl fluorophore (FL)‐tagged electron‐rich NHC ligand (FL‐NHC) and an electron‐deficient NHC ligand (FL‐NHC_ewg) were prepared. The fluorescence of the dansyl fluorophore is quenched as long as it is in close vicinity to ruthenium, but increases strongly upon dissociation of the respective fluorophore‐tagged ligand. In this manner, it was shown for ring‐opening metathesis ploymerization (ROMP) reactions at room temperature that the NHC_ewg ligand normally acts as the leaving group, whereas the other NHC ligand remains ligated to ruthenium.     

The trans influence in mer‐tri­chloro­nitridobis­(tri­phenyl­arsine)­ruthenium(VI)

The title compound, mer‐[RuCl₃N(C₁₈H₁₅As)₂], is the first structurally characterized example of a nitride complex in which ruthenium is six‐coordinated to monodentate ligands only. The Ru[triple‐bond]N bond length [1.6161 (15) Å] is relatively long, and the trans influence of the nitride ligand is reflected by the difference between the Ru—Cl_trans and Ru—Cl_cis bond lengths [0.1234 (4) Å]. The N—Ru—Cl_trans axis is sited on a twofold axis.     

Rhodium‐ and ruthenium‐complex‐catalyzed condensation of ferrocene‐containing dithiols and diols with diarylsilanes to give silaferrocenophanes and ferrocene polymers

1,1′‐Ferrocenedithiol reacts with di(4‐methoxyphenyl)silane, diphenylsilane, and di(4‐fluorophenyl)silane in the presence of RhCl(PPh₃)₃ catalyst to give mixtures of 2,2‐diaryl‐1,3‐dithia‐2‐sila[3]ferrocenophanes (1a–3a) and ? (Fc? S? SiAr₂? S) _n? (Fc = 1,1′‐ferrocenylene; 1b: Ar = C₆H₄OMe‐4; 2b: Ar = Ph; 3b: Ar = C₆H₄F‐4). The products are isolated and characterized by NMR spectroscopy and elemental analyses. The polymers 1b–3b, obtained from a toluene‐soluble fraction of the products, show GPC elution patterns corresponding to M_n values of 2700–4600 (polystyrene standards). The UV–vis spectra of the ferrocenophanes and polymers exhibit a d–d transition peak at about 440 nm, while the polymers show a π–π* transition peak at 320–330 nm. The cyclic voltammograms of 3a (Ar = C₆H₄F ? 4) and 3b show a reversible redox of the iron center at 0.27 V and 0.35 V (Ag⁺/Ag) respectively. Reaction of 1,1′‐ferrocenedimethanol with diphenylsilane in the presence of RuCl₂(PPh₃)₃ catalyst results in selective formation of 3,3‐diphenyl‐2,4‐dioxa‐3‐sila[5]ferrocenophane ( 4 ), whose structure was determined by X‐ray crystallography. Copyright © 2001 John Wiley & Sons, Ltd.     

trans‐Di­chloro­bis­(tri­phenyl­phosphine‐P)­platinum(II)

Two different crystals (A and B) were used to structurally characterize trans‐[PtCl₂(PPh₃)₂] and to study random and systematic errors in derived parameters. The compound is isomorphous with trans‐[PdCl₂(PPh₃)₂] and with one of the polymorphs of trans‐[PtMeCl(PPh₃)₂] reported previously. Half‐normal probability plot analyses based on A and B show realistic s.u.'s and negligible systematic errors. R.m.s. calculations give very good agreement between A and B, 0.0088 Å. Important geometrical parameters are Pt—P = 2.3163 (11) Å, Pt—Cl = 2.2997 (11) Å, P—Pt—Cl = 87.88 (4) and 92.12 (4)°. Half‐normal probability plots and r.m.s. calculations were also used to compare the title compound with the palladium analogue, showing small systematic differences between the compounds. The torsion angles around the Pt—P bond were found to be very similar to those reported for isomorphous complexes, as well as to the torsion angles around the Pt—As bond in trans‐[PtCl₂(AsPh₃)₂]. The NMR coupling constants for the title compound are similar to Pt—P coupling constants reported for analogous trans complexes.